Top Markets
Coin of the day
MYND Life Sciences Inc. MYND Life Sciences Inc.

MYND Life Sciences Inc.

MYND
Rank in Stocks #36741
Headquartered in Kelowna, Canada, MYND Life Sciences Inc. operates as a... Headquartered in Kelowna, Canada, MYND Life Sciences Inc. operates as a neuro-pharmaceutical enterprise focused on creating innovative therapies for depressive disorders. The company conducts scientific research and clinical trials across Canada and the United States to develop drugs derived from neuro-anti-inflammatory compounds. A significant part of their work involves the study and development of psilocin and psilocybin extracts, as well as their synthetic analogs.
Share Price
$0.05032369
Last synced: 2025-05-20
Market Cap
$2.37M
Change (1 day)
0.44%
Change (1 year)
0.00%
Country
CA
Trade MYND Life Sciences Inc. (MYND)

Category

P/B ratio for MYND Life Sciences Inc. (MYND)
P/B ratio as of 2026 TTM: 0
According to MYND Life Sciences Inc. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for MYND Life Sciences Inc. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
6.3419 -
US
6.2413 -
NL
- -
CH
- -
KR
3.4612 -
BE